prostate cancermHSPCmCRPChigh risk biochemical recurrence177Lu-PSMA-617androgen receptor pathway inhibitorschemotherapypoly-ADP ribose polymerase (PARP) inhibitors
…177Lu-PSMA-617 in this disease space. Finally, as patients with prostate cancer are living longer, the review focuses on understanding and mana…